Sion Medical Company
"Dermatological Wound Care and Surgical Products."
Sion Medical manufactures single-use skin-cleansing and dermatological treatments, advanced wound care products, burn remedies, and surgical solutions for the professional healthcare sector. The company is focused on the development of skin asepsis solutions and generic creams, ointments, and gels for topical dermatological, burn, and wound applications.
Sion Medical is part of the Sion Medical Group, dedicated to the research, development, marketing, sale, and distribution of healthcare solutions for the management of wound care and infection prevention in Romania and Europe. The company currently operates through five locations worldwide, with two manufacturing sites in Israel and additional sales and logistics divisions (Sion Brands) in Europe and North America.
The company's quality system is accredited to ISO 9001:2008, EN ISO 13485:2012, and ISO 13485:2003 CMDCAS standards and is in compliance with CFR Title 21 Parts 210, 211, and 820. Its products bear CE Mark certification as well as FDA approval.
In March 2020, Sion Medical won a fast-track tender by the Ministry of Health to set up a production line for N95 masks to provide medical staff with protection against COVID-19.
Combating Coronavirus Pandemic:
Sion Medical's solution helps address the Coronavirus Pandemic.
Sion Medical manufactures single-use skin-cleansing and dermatological treatments, advanced wound care products, burn remedies, and surgical solutions for the professional healthcare sector. The company is focused on the development of skin asepsis solutions and generic creams, ointments, and gels for topical dermatological, burn, and wound applications.
Sion Medical is part of the Sion Medical Group, dedicated to the research, development, marketing, sale, and distribution of healthcare solutions for the management of wound care and infection prevention in Romania and Europe. The company currently operates through five locations worldwide, with two manufacturing sites in Israel and additional sales and logistics divisions (Sion Brands) in Europe and North America.
The company's quality system is accredited to ISO 9001:2008, EN ISO 13485:2012, and ISO 13485:2003 CMDCAS standards and is in compliance with CFR Title 21 Parts 210, 211, and 820. Its products bear CE Mark certification as well as FDA approval.
In March 2020, Sion Medical won a fast-track tender by the Ministry of Health to set up a production line for N95 masks to provide medical staff with protection against COVID-19.
Combating Coronavirus Pandemic:
Sion Medical's solution helps address the Coronavirus Pandemic.
Technology:
COVID Treatments
Industry:
Preventive Tech
Headquarters:
Israel
Founded Date:
2001
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership